SU1242173A1 - Chewing gum - Google Patents
Chewing gum Download PDFInfo
- Publication number
- SU1242173A1 SU1242173A1 SU833656747A SU3656747A SU1242173A1 SU 1242173 A1 SU1242173 A1 SU 1242173A1 SU 833656747 A SU833656747 A SU 833656747A SU 3656747 A SU3656747 A SU 3656747A SU 1242173 A1 SU1242173 A1 SU 1242173A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- flavoring
- chewing gum
- powder
- gum
- sugar
- Prior art date
Links
- 235000015218 chewing gum Nutrition 0.000 title claims description 11
- 229940112822 chewing gum Drugs 0.000 title claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 208000002925 dental caries Diseases 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 3
- 210000000991 chicken egg Anatomy 0.000 claims description 3
- 235000013379 molasses Nutrition 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 235000013601 eggs Nutrition 0.000 claims description 2
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 230000000069 prophylactic effect Effects 0.000 claims description 2
- 159000000007 calcium salts Chemical class 0.000 claims 2
- 235000014633 carbohydrates Nutrition 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 235000013355 food flavoring agent Nutrition 0.000 claims 2
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 239000005454 flavour additive Substances 0.000 claims 1
- 239000000242 nostrum Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 5
- 210000003296 saliva Anatomy 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 2
- 230000037444 atrophy Effects 0.000 description 2
- 230000033558 biomineral tissue development Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001055 chewing effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- -1 flavoring Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Confectionery (AREA)
- Medicinal Preparation (AREA)
Description
II
Изобретение относитс к медицине, а именно к стоматологии, и касаетс лечебно-профилактических жевательньщ резинок, используе:мых дл профилактики кариеса и парадрнтоза.The invention relates to medicine, namely to dentistry, and relates to therapeutic and prophylactic chewing gums, which are used to prevent caries and parasites.
Цель изобретени - повьшение ка- риесопрофилактической и антипарадон- тозной активности за счет введени в состав резинки глицерина, лимонной кислоты, ароматизатора, сахарной пудры , патоки, порошка скорлупы куриных иц при определенном соотношении компонентов.The purpose of the invention is to increase the caries-prophylactic and anti-paradone activity by introducing glycerin, citric acid, flavor, sugar powder, molasses, chicken egg powder into the gum composition at a certain ratio of components.
Жевательна резинка приобретает кариесопрофилактическую и антипарадонтоз ную активность следующим образом .Chewing gum acquires caries-prophylactic and anti-paradontic activity as follows.
В состав ее введены сахарна : пудра , глицерин, патока, ароматизатор, кислота лимонна , а в качестве источника кальци используют порошок скорлупы куриных иц.The composition of its introduced sugar: powder, glycerin, syrup, flavoring, citric acid, and as a source of calcium using chicken egg powder.
Пример 1. У пациентки М., 34 года, страдакщей кариесом была использована жевательна резинка следующегЬ состав€1, %:Example 1. Patient M., 34 years old, suffering from caries, was used chewing gum with the following composition of € 1,%:
ОсноваThe foundation
Сахарна пудра Патока .Глицерин Ароматизатор Кислота лимонна Пор.ошок скорлупы куриных ицSugar powder Molasses. Glycerin Flavoring Acid citric Poroshok of chicken eggs shells
15,015.0
45,045.0
15,015.0
0,40.4
0,50.5
0,50.5
5,05.0
После использовани жевательной резинки данного состава отмечалось повышение содержани кальци в слюСоставитель А.Пащук Редактор Н. Бобкова Техред О,ГортвайAfter using chewing gum of this composition, an increase in calcium content was observed in the slime. Compiler A. Pashchuk
Корре ПодпиCorre Poppy
3639/9 Тираж 6603639/9 Circulation 660
ВНИШ1И Государственного комитета СССРVNISH1I USSR State Committee
по делам изобретений и открытий 113035, Москва, Ж-35, Раушска наб., д. 4/5for inventions and discoveries 113035, Moscow, Zh-35, Raushsk nab., 4/5
Производственно-полиграфическое предпри тие,г.Ужгород,ул.Проектна , 4Production and printing company, Uzhgorod, Projecto st., 4
00
5five
421737421737
не до 0,37 мг-%, првьтение рН до 6,6 (EI известной резинке соответственно 0,2 мг-% и рН 6,5). Минерализаци слюны и ее ощелачивание свиде- 5 тельствует о высоком кариесопрофилак- тическом эффекте жевательной резинки , по сравнению с известной резинкой.not up to 0.37 mg-%, making pH up to 6.6 (EI of a known elastic band, respectively, 0.2 mg-% and pH 6.5). Mineralization of saliva and its alkalization indicate a high caries-prophylactic effect of chewing gum, compared with the known gum.
Торможение атрофии альвеомерного отростка, вы вленное при применении жевательной резинки, свидетельствует об антипарадонтозной активности резинки. У известной резинки данна активность не вы влена.The inhibition of atrophy of the alveomer process, which was observed with the use of chewing gum, indicates the anti-paradontic activity of the gum. In the known gum, this activity is not identified.
П р и м е р 2. Больному К., 45 лет давали жевательную резинку следующего состава, Г %:PRI mme R 2. Patient K., 45 years old, was given a chewing gum of the following composition, G%:
ОсноваThe foundation
Сахарна Sugar
пудраpowder
ПатокаSyrup
Глицерин Glycerol
АроматизаторFlavoring
КислотаAcid
лимонна lemon
Порошок скорлУPowder Powder
пы куриньрс ицpy kuinrs itz
Через час после жевани отмеча- 1лось повьшение содержани кальци в слюне до 0,38 мг.% (в известной 0,2 мг %) и повьшение рН слюны до 6,71 (в известной 6,6). Минерализаци слюны и ее ощелачивание свидетельствует о высоком кариесопрофи- лактическом эффекте жевательной резинки . Торможение атрофии альвеомерного отростка, вы вленное при применении жевательной резинки, свидетельствует об антипарадонтозной активности резинки, которой не вы влено у известной резинки.An hour after chewing, there was an increase in the calcium content in saliva to 0.38 mg.% (In the known 0.2 mg%) and an increase in the pH of the saliva to 6.71 (in the known 6.6). Mineralization of saliva and its alkalization indicate a high caries-prophylactic effect of chewing gum. The inhibition of the atrophy of the alveomeric process, revealed by the use of chewing gum, testifies to the anti-paradontic activity of the gum, which is not found in the known gum.
2020
5five
30thirty
5five
22,022.0
55,055.0
25,025.0
1,01.0
1,01.0
v.v.
15,015.0
Корректор И. Эрдейи ПодписноеProofreader I. Erdeyi Subscription
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU833656747A SU1242173A1 (en) | 1983-09-14 | 1983-09-14 | Chewing gum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SU833656747A SU1242173A1 (en) | 1983-09-14 | 1983-09-14 | Chewing gum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1242173A1 true SU1242173A1 (en) | 1986-07-07 |
Family
ID=21087016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU833656747A SU1242173A1 (en) | 1983-09-14 | 1983-09-14 | Chewing gum |
Country Status (1)
| Country | Link |
|---|---|
| SU (1) | SU1242173A1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3856G2 (en) * | 2007-11-23 | 2009-10-31 | Валериу ФАЛА | Chewing gum (variants) |
| MD3857G2 (en) * | 2007-12-21 | 2009-10-31 | Валериу ФАЛА | Chewing gum for dental enamel remineralization (variants) |
| MD3878G2 (en) * | 2008-02-18 | 2009-11-30 | Валериу ФАЛА | Chewing gum (variants) |
| MD3900G2 (en) * | 2007-12-21 | 2009-12-31 | Валериу ФАЛА | Chewing gum with antistress and analgetic action (variants) |
-
1983
- 1983-09-14 SU SU833656747A patent/SU1242173A1/en active
Non-Patent Citations (1)
| Title |
|---|
| Патент US № 3655866, кл. А 61 К 9/68, 1972. * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD3856G2 (en) * | 2007-11-23 | 2009-10-31 | Валериу ФАЛА | Chewing gum (variants) |
| MD3857G2 (en) * | 2007-12-21 | 2009-10-31 | Валериу ФАЛА | Chewing gum for dental enamel remineralization (variants) |
| MD3900G2 (en) * | 2007-12-21 | 2009-12-31 | Валериу ФАЛА | Chewing gum with antistress and analgetic action (variants) |
| MD3878G2 (en) * | 2008-02-18 | 2009-11-30 | Валериу ФАЛА | Chewing gum (variants) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2794388B2 (en) | Solid dosage form product for alleviating dry mouth symptoms | |
| ES403435A1 (en) | Slow release pharmaceutical compositions | |
| RU2006147223A (en) | SUSTAINABLE AT CHEESE CAPSULE | |
| JPS62502967A (en) | Treatment of non-ulcer dyspepsia | |
| DE3377063D1 (en) | Benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them | |
| SU1242173A1 (en) | Chewing gum | |
| US4265877A (en) | Composition containing sodium fluoride in a chewing gum base | |
| US4405610A (en) | Drug for curing inflammatory and/or degenerative and/or atrophic mucous-membrane diseases | |
| JPS57165312A (en) | Production of oral composition | |
| ES8505379A1 (en) | Derivatives of dihydropyridine and production thereof. | |
| US2798837A (en) | Achlorhydria composition | |
| US3822349A (en) | Vasoconstrictor-antihistamine composition for the treatment of hypertrophied oral tissue | |
| JP2012527448A (en) | Use of D-aspartic acid and L-aspartic acid or combinations of salts of these acids for the treatment of male infertility | |
| BG94824A (en) | TABLET CONTAINING SODIUM 2-MERCAPTOETHANESULFONATE (MESNA) AS ACTIVE SUBSTANCE AND METHOD FOR ITS PREPARATION | |
| RU2131720C1 (en) | Paste for filling root canals of a tooth | |
| US2203436A (en) | Masticatory | |
| SU1209221A1 (en) | Tooth elixir | |
| Marks et al. | A proposed new method for the treatment of dry mouth | |
| RU2257212C1 (en) | Method of correcting emitting reflex during prosthesis operation | |
| AR008245A1 (en) | DERIVATIVES OF ACETIC ACID, USE OF THE SAME IN THE MANUFACTURE OF A THERAPEUTIC AGENT AND PROCESS TO PREPARE SUCH DERIVATIVES | |
| SU1223910A1 (en) | Tooth paste | |
| YU44232B (en) | Process for obtaining alcalic salts of pyroxicame excreted onto pharmaceutical acceptable carrier | |
| SU1142930A1 (en) | Compound for setting dental prosthesis | |
| RU2149011C1 (en) | Agent prepared of natural vegetable products for prophylaxis of mouth cavity inflammatory diseases | |
| WO2022102679A1 (en) | Alveolar bone resorption inhibitor and formation accelerator, each containing daidzein as active ingredient |